drug
metoprolol succinate ER
Marketedupdated 3mo agoby Melinta Therapeutics LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Trials studying metoprolol succinate ER
- phase3Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
- phase1A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
- phase4Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 9, 2035
~8.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Jul 9, 2035formulationUS 9504655
- Jul 9, 2035formulationUS 9504655
- Jul 9, 2035formulationUS 9504655
- Jul 9, 2035formulationUS 9504655
- Jul 9, 2035formulationUS 9700530
- Jul 9, 2035formulationUS 9700530
- Jul 9, 2035formulationUS 9700530
- Jul 9, 2035formulationUS 9700530
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that